Search Results - "rhythm control"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
    COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE

    COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL... by L. E. Kuvshinova, N. V. Furman, P. V. Dolotovskaya, Ya. P. Dovgalevsky

    Published 2015-09-01

    Aim. To compare direct medical costs of dabigatran and warfarin therapy in patients with non-valvular atrial fibrillation (NVAF) during preparation for elective cardioversion. Material and methods. An open non-randomized study was conducted to evaluate direct medical costs (cost of drug, cost of the...

    Full description

    Subjects: Get full text
    Article

    Save to List
    Saved in:
  2. 2
    STATE OF THE ART PHARMACOLOGICAL THERAPY FOR ATRIAL FIBRILLATION

    STATE OF THE ART PHARMACOLOGICAL THERAPY FOR ATRIAL FIBRILLATION by S. G. Kanorsky, Yu. S. Kovalenko

    Published 2017-08-01

    Pharmacological therapy remains the primary approach to atrial fibrillation (AF). Management of all AF patients includes the decision on rate or rhythm control. The latter means antiarrhythmic drugs application that are being selected primarily by safety reasons and depend on individual characterist...

    Full description

    Subjects: Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Early Rhythm Control of Atrial Fibrillation in Cancer Survivors: A Nationwide Population‐Based Study

    Early Rhythm Control of Atrial Fibrillation in Cancer Survivors: A Nationwide Population‐Based Study by Seokmoon Han, So‐Ryoung Lee, Eue‐Keun Choi, Bongseong Kim, Kyung‐Do Han, JungMin Choi, Kyung‐Yeon Lee, Hyo‐Jeong Ahn, Soonil Kwon, Seil Oh, Gregory Y. H. Lip

    Published 2025-07-01

    Background Although early rhythm control (ERC) is effective in reducing stroke in patients with atrial fibrillation (AF), its benefits have not been well elucidated in cancer survivors. This study aimed to compare the risk of ischemic stroke between ERC and usual care in cancer survivors with AF. Me...

    Full description

    Subjects: Get full text
    Article

    Save to List
    Saved in:
  4. 4
    FEATURES OF THE CARDIOVERSION IN ATRIAL FLUTTER AND FIBRILLATION IN ERA OF NEW ANTICOAGULANTS: PRACTICAL CARDIOLOGIST VIEW

    FEATURES OF THE CARDIOVERSION IN ATRIAL FLUTTER AND FIBRILLATION IN ERA OF NEW ANTICOAGULANTS: PRACTICAL CARDIOLOGIST VIEW by S. A. Zenin, A. V. Fedoseenko, O. V. Kononenko, O. V. Pyataeva

    Published 2015-09-01

    Strategies for the management of patients with atrial fibrillation (heart rhythm or heart rate control) are considered. The advantages of these methods, especially the implementation are presented. Based on their own data, authors give an algorithm to select the management strategy in particular pat...

    Full description

    Subjects: Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Atrial fibrillation: Yesterday, today, and tomorrow

    Atrial fibrillation: Yesterday, today, and tomorrow by S. G. Kanorskiy, P. A. Galenko-Yaroshevsky, S. N. Alekseenko, S. P. Golitsyn

    Published 2025-06-01

    Background. Advances in electrophysiological research have led to a modern understanding of the mechanisms of atrial fibrillation — the most common sustained cardiac arrhythmia, which poses a risk of severe, often disabling, and fatal complications. Although there have also been advances in pharmaco...

    Full description

    Subjects: Get full text
    Article

    Save to List
    Saved in:
  6. 6
    Atrial Fibrillation in Diabetes: Pathogenesis and Targeted Rhythm Control Strategies

    Atrial Fibrillation in Diabetes: Pathogenesis and Targeted Rhythm Control Strategies by Konstantinos Grigoriou, Paschalis Karakasis, Konstantinos Pamporis, Panagiotis Theofilis, Dimitrios Patoulias, Efstratios Karagiannidis, Barbara Fyntanidou, Antonios P. Antoniadis, Nikolaos Fragakis

    Published 2025-07-01

    Diabetes mellitus and atrial fibrillation (AF) frequently coexist, creating a complex bidirectional relationship that exacerbates cardiovascular risk and challenges clinical management. Diabetes fosters a profibrotic, pro-inflammatory, and proarrhythmic atrial substrate through a constellation of pa...

    Full description

    Subjects: Get full text
    Article

    Save to List
    Saved in:
  7. 7
    Personified approach to diagnostics and treatment of atrial fibrillation. Diagnostic stage (part 2)

    Personified approach to diagnostics and treatment of atrial fibrillation. Diagnostic stage (part 2) by E. A. Praskurnichii, O. I. Morozova

    Published 2021-06-01

    The article presents a review of mechanisms, diagnostics and possible predictors of atrial fibrillation recurrence, as well as the analysis of available scientifically proved therapeutic approaches to the treatment of patients with this arrhythmia. The role of anticoagulant therapy both in the conte...

    Full description

    Subjects: Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Personified approach to diagnostics and treatment of atrial fibrillation. Diagnostic stage (part 1)

    Personified approach to diagnostics and treatment of atrial fibrillation. Diagnostic stage (part 1) by E. A. Praskurnichii, O. I. Morozova

    Published 2021-06-01

    The article presents a review of mechanisms, diagnostics and possible predictors of atrial fibrillation recurrence, as well as the analysis of available scientifically proved therapeutic approaches to the treatment of patients with this arrhythmia. The role of anticoagulant therapy both in the conte...

    Full description

    Subjects: Get full text
    Article

    Save to List
    Saved in:
  9. 9
    Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part I: Study Rationale, Design and Assessment of Effectiveness

    Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part I: Study Rationale, Design and Assessment of Effectivene... by N. Yu. Mironov, Yu. A. Yuricheva, V. V. Vlodzyanovskiy, S. F. Sokolov, Kh. M. Dzaurova, S. P. Golitsyn, Yu. V. Shubik, M. V. Berman, M. M. Medvedev, A. E. Rivin, D. S. Parkhomchuk, A. E. Barybin, D. А. Balandin, R. E. Batalov, D. S. Terekhov, I. V. Evstifeev, I. R. Kildeev, O. V. Pyataeva, S. A. Zenin

    Published 2021-05-01

    Aim. We aimed to assess safety and effectiveness of class III antiarrhythmic drug Refralon for conversion of atrial fibrillation (AFib) and flutter (AFl) in post-registration trial and to compare data of primary center (National medical research center in cardiology) with data of other hospitals.Mat...

    Full description

    Subjects: Get full text
    Article

    Save to List
    Saved in:
  10. 10
    ATRIAL FIBRILLATION AND CHRONIC HEART FAILURE: PRACTICAL ASPECTS AND DISCUSSION ISSUES OF RATIONAL PHARMACOTHERAPY

    ATRIAL FIBRILLATION AND CHRONIC HEART FAILURE: PRACTICAL ASPECTS AND DISCUSSION ISSUES OF RATIONAL PHARMACOTHERAPY by Yu. А. Bunin, S. V. Miklishanskaya

    Published 2017-12-01

    Atrial fibrillation (AF), being both a cause and a consequence of chronic heart failure (CHF), occurs with it significantly more often than in the general population. Prevention and treatment of AF in patients with CHF has its own specifics and presents certain difficulties for practical physicians...

    Full description

    Subjects: Get full text
    Article

    Save to List
    Saved in:
  11. 11
    Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part II: Assessment of Safety

    Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part II: Assessment of Safety by N. Yu. Mironov, Yu. A. Yuricheva, V. V. Vlodzyanovskiy, S. F. Sokolov, Kh. M. Dzaurova, S. P. Golitsyn, Yu. V. Shubik, M. V. Berman, M. M. Medvedev, A. E. Rivin, D. S. Parkhomchuk, A. E. Barybin, D. А. Balandin, R. E. Batalov, D. V. Terekhov, I. V. Evstifeev, I. R. Kildeev, O. V. Pyataeva, S. A. Zenin

    Published 2021-11-01

    Aim. We aimed to assess safety and effectiveness of class III antiarrhythmic drug Refralon for conversion of atrial fibrillation (AFib) and flutter (AFl) in post-registration trial and to compare data of primary center (National medical research center in cardiology) with data of other hospitals.Mat...

    Full description

    Subjects: Get full text
    Article

    Save to List
    Saved in:
  12. 12
    2020 Clinical guidelines for Atrial fibrillation and atrial flutter

    2020 Clinical guidelines for Atrial fibrillation and atrial flutter by M. G. Arakelyan, L. A. Bockeria, E. Yu. Vasilieva, S. P. Golitsyn, E. Z. Golukhova, M. V. Gorev, K. V. Davtyan, O. M. Drapkina, E. S. Kropacheva, E. A. Kuchinskaya, L. Yu. Lajovich, N. Yu. Mironov, I. E. Mishina, E. P. Panchenko, A. Sh. Revishvili, F. G. Rzayev, B. A. Tatarsky, M. D. Utsumueva, O. O. Shakhmatova, N. B. Shlevkov, A. V. Shpektor, D. A. Andreev, E. A. Artyukhina, O. L. Barbarash, A. S. Galyavich, D. V. Duplyakov, S. A. Zenin, D. S. Lebedev, E. N. Mikhailov, N. A. Novikova, S. V. Popov, A. G. Filatov, E. V. Shlyakhto, Yu. V. Shubik

    Published 2021-08-01

    Russian Society of Cardiology (RSC).With the participation of Russian Scientific Society of Clinical Electrophysiology, Arrhythmology and Cardiac Pacing, Russian Association of Cardiovascular Surgeons.Approved by the Scientific and Practical Council of the Russian Ministry of Health.

    Subjects: Get full text
    Article

    Save to List
    Saved in:
  13. 13
    2016 ESC GUIDELINES FOR THE MANAGEMENT OF ATRIAL FIBRILLATION DEVELOPEDIN COLLABORATION WITH EACTS

    2016 ESC GUIDELINES FOR THE MANAGEMENT OF ATRIAL FIBRILLATION DEVELOPEDIN COLLABORATION WITH EACTS by Paulus Kirchhof, Stefano Benussi, Dipak Kotecha, Anders Ahlsson, Dan Atar, Barbara Casadei, Manuel Castella, Hans-Christoph Diener, Hein Heidbuchel, Jeroen Hendriks, Gerhard Hindricks, Antonis S. Manolis, Jonas Oldgren, Bogdan Alexandru Popescu, Ulrich Schotten, Bart Van Putte, Panagiotis Vardas

    Published 2017-08-01

    The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC)Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESCEndorsed by the European Stroke Organisation (ESO)

    Subjects: Get full text
    Article

    Save to List
    Saved in:
  14. 14
    2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

    2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) by G. Hindricks, T. Potpara, N. Dagres, E. Arbelo, J. J. Bax, C. Blomstrӧm-Lundqvist, G. Boriani, M. Castella, G.-A. Dan, P. E. Dilaveris, L. Fauchier, G. Filippatos, J. M. Kalman, M. La Meir, D. A. Lane, J.-P. Lebeau, M. Lettino, G. Y.H. Lip, F. J. Pinto, G. Neil Thomas, M. Valgimigli, I. C. Van Gelder, B. P. Van Putte, C. L. Watkins

    Published 2021-10-01

    2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

    Subjects: Get full text
    Article

    Save to List
    Saved in:

Search Tools: